✦ LIBER ✦

Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis

✍ Scribed by Lebrun, C.; Debouverie, M.; Vermersch, P.; Clavelou, P.; Rumbach, L.; de Seze, J.; Wiertlevski, S.; Defer, G.; Gout, O.; Berthier, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer and multiple sclerosis in the era

✍ Christine Lebrun; Patrick Vermersch; David Brassat; Gilles Defer; Lucien Rumbach 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 181 KB

Diagnosis and disease modifying treatmen

✍ Zajicek, J 📂 Article 📅 2005 🏛 BMJ Publishing Group 🌐 English ⚖ 88 KB

Impact of disease-modifying treatments i

✍ Lebrun, C; Debouverie, M; Jeannin, S; Pittion-Vouyovitch, S; Bayreuther, C; Bert 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 196 KB

Established and novel disease-modifying

✍ Cross, A. H.; Naismith, R. T. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

Effects of disease modifying treatments

✍ Giancarlo Comi 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 176 KB

Disease Burden Among Patients with Multi

✍ Narayanan, S.; Khan, H.; Gabriele, S.; White, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB